Efficacy of cladribine tablets 3.5 mg/kg in patients with relapsing multiple sclerosis aged above and below 45 years; clarity and clarity extension

Authors
Category Primary study
JournalJournal of the Neurological Sciences
Year 2019
This article has no abstract
Epistemonikos ID: d28f6f23cd93afeede8bc15cf9bb472e5855d801
First added on: Mar 31, 2022